Eagle Pharmaceuticals

267 articles about Eagle Pharmaceuticals

• Eagle Pharmaceuticals Schedules Second Quarter Earning Release And Conference Call

  5/1/2014

• Eagle Pharmaceuticals To Present At 39th Annual Deutsche Bank Health Care Conference

  4/29/2014

• Eagle Pharmaceuticals’ Exclusive Licensor Granted U.S. Patent For Dantrolene In The Treatment Of Heat Stroke

  4/1/2014

• NDA For Eagle Pharmaceuticals' Orphan Drug Ryanodex® For The Treatment Of Malignant Hyperthermia Accepted By FDA, Priority Review Granted

  3/20/2014

• Eagle Pharmaceuticals Eyes $50 Million In IPO

  2/12/2014

• Eagle Pharmaceuticals Files For A $50 Million IPO

  12/23/2013

• OncoGenex Pharmaceuticals Inc. Announces Out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals

  9/2/2008